Analysis Biomolecular Interactions of TREM2 with Clusterin by BLI (CAT#: STEM-MB-0237-CJ)

Introduction

Triggering receptor expressed on myeloid cells 2 (TREM2) is a protein that in humans is encoded by the TREM2 gene. TREM2 is expressed on macrophages, immature monocyte-derived dendritic cells, osteoclasts, and microglia, which are immune cells in the central nervous system. TREM2 is overexpressed in many tumor types and has anti-inflammatory activities. In addition, TREM2 is a transmembrane receptor expressed in cells of the myeloid lineage, and its association with Alzheimer's disease supports the involvement of immune and inflammatory pathways in the cause of the disease, rather than as a consequence of the disease. The clusterin is ubiquitously expressed protein, with one isoform located in the nucleus and an 80 kDa secreted glycoprotein. Secreted clusterin is involved in lipid transport and is released in response to cell stress where it protects the cell by reducing oxidative stress and binding to misfolded proteins.

Add to Cart Please Inquire

Principle Applications Procedure Materials Notes Related Products

Principle

Bio-Layer Interferometry (BLI) is an optical technique for measuring macromolecular interactions by analyzing interference patterns of white light reflected from the surface of a biosensor tip. BLI experiments are used to determine the kinetics and affinity of molecular interactions. In a BLI experiment, one molecule is immobilized to a Dip and Read Biosensor and binding to a second molecule is measured. A change in the number of molecules bound to the end of the biosensor tip causes a shift in the interference pattern that is measured in real-time.

Applications

Neurobiology；Pharmacology

Procedure

1. Detect Buffers and prepare samples. BLI experiments are set up with one molecule immobilised on the surface of the biosensor (load sample) and a second molecule in solution (the analytical sample).
2. Fix the load sample on the biocompatible biosensor while the analytical sample is in solution.
3. The biosensor tip is immersed in the solution so that the target molecule begins to bind to the analysis sample.
4. Set up and run the BLI experiment. Molecules bound to or dissociated from the biosensor can generate response curves on the BLI system; unbound molecules, changes in the refractive index of the surrounding medium or changes in flow rate do not affect the interferogram pattern.
5. Collect and analyse data on the BLI's system.

Materials

• Equipment: Fortebio Bio-Layer Interferometry (BLI)
• Sample Type: DNA, RNA, Protein, Antibodies, Peptides, Small Molecules
• Optionals: Human brain perivascular cells

Other recommended products

Analysis Biomolecular Interactions of Neutralizing Antibody (NAb) CAP256LS with HIV-1 Envelope V1V2 Site by BLI (CAT#: STEM-MB-0145-CJ)
Analysis Biomolecular Interactions of Pba and PG Sacculi by BLI (CAT#: STEM-MB-0234-CJ)
Analysis Biomolecular Interactions of Nluc-ch2C5 and HRP-ch2C5 to S-RBD Protein by BLI (CAT#: STEM-MB-0170-CJ)
Analysis Kinetics of PTH1–34 by BLI (CAT#: STEM-MB-0280-CJ)
Analysis Kinetics of Aptamer GO18-T-d by BLI (CAT#: STEM-MB-0271-CJ)
Analysis Biomolecular Interactions of Gal-1 and Gal-3 With Von Willebrand Factor (VWF) by BLI (CAT#: STEM-MB-0144-CJ)
Analysis Kinetics of Monoclonal Antibodies Targeting NT-pro-BNP by BLI (CAT#: STEM-MB-0270-CJ)
Analysis Biomolecular Interactions of TREM2 with LDL by BLI (CAT#: STEM-MB-0239-CJ)